UK renal registry 14th annual report: Chapter 9 biochemical variables amongst UK adult dialysis patients in 2010: National and centre-specific analyses

Nephron - Clinical Practice

Volumn 120, Issue SUPPL.1, 2012, Pages

  Pruthi, Rishi ^a   Pitcher, David ^a   Dawnay, Anne ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Bicarbonate; Biochemical variables; Calcium; Cholesterol; Dialysis; Haemodialysis; Parathyroid hormone; Peritoneal dialysis; Phosphate; Quality improvement

Indexed keywords

ALKALINE PHOSPHATASE; BICARBONATE; CALCIUM; CHOLESTEROL; CINACALCET; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHATE; SERUM ALBUMIN;

ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; BIOCHEMISTRY; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; GOOD CLINICAL PRACTICE; HEALTH CARE QUALITY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOPHOSPHATEMIA; IMMUNOASSAY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MEDICAL SOCIETY; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SURVIVAL; TOTAL QUALITY MANAGEMENT; UNITED KINGDOM; AGED; BLOOD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; MALE; MIDDLE AGED; REGISTER; RESIDENTIAL CARE; STANDARD; STATISTICS;

ADULT; AGED; BICARBONATES; CALCIUM; CATCHMENT AREA (HEALTH); CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; GUIDELINE ADHERENCE; HEMODIALYSIS UNITS, HOSPITAL; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RENAL DIALYSIS; YOUNG ADULT;

EID: 84866269417     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000342852     Document Type: Article

References (19)

1. Renal association. Clinical practice guidelines. 5th edition. Haemodialysis. http://www.renal.org/Clinical/GuidelinesSection/Haemodialysis. aspx
2. Ansell D, Feehally J, Feest T, Tomson C, Williams AJ, Warwick G: U.K. Renal registry report 2007. Chapter 9. Management of biochemical variables. UK Renal Registry, Bristol, UK 2007
3. Ansell D, Tomson CRV: Chapter 15 uk renal registry annual report: U.K. Renal registry, ukrr database, validation and methodology. Nephron Clin Pract 2009;111(suppl 1):c277-85.Epub 2009 Mar 26
4. Morton AR, Garland JS, Holden RM: Is the calcium correct? Measuring serum calcium in dialysis patients. Semin Dial;23:283-289
5. KDOQI: Clinical practice guidelines for bone metabolism and disease in chronic kidney disease http://www.kidney.org/professionals/KDOQI/guidelines- bone/index.htm
6. Spiegelhalter DJ: Funnel plots for comparing institutional performance. Statistics in Medicine 2005;24:1185-1202 (Pubitemid 40485757)
7. Renal association. Clinical practice guidelines. 4th edition. Module 2 complications http://www.Renal.Org/clinical/oldguidelines.Aspx
8. Renal association. Clinical practice guidelines. 5th edition CKD mineral and Bone disorders http://www.renal.org/Clinical/GuidelinesSection/CKD-MBD.aspx
9. Almond A, Ellis AR, Walker SW: Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease. Ann Clin Biochem 2011;49:63-67
10. Garrett G, Goldsmith DJA: Parathyroid hormone measurements, guidelines statements and clinical treatments: a real world cautionary tale. Ann Clin Biochem 2011;49:4-6
11. Gardham C, Stevens PE, Delaney MP, LeRoux M, Coleman A, Lamb EJ: Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving haemodialysis. Clin J Am Soc Nephrol 2010;5:1261-1267
12. Sturgeon CM, Sprague SM, Metcalfe W: Variation in parathyroid hormone immunoassay results-a critical governance issue in the management of chronic kidney disease. Nephrol Dial Transplant 2011; 26:3440-3445
13. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-780 (Pubitemid 44215354)
14. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR: Changes in serum calcium, phosphate, and pth and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int 2006;70:351-357 (Pubitemid 44086585)
15. Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT: The kidney disease outcomes quality initiative (k/doqi) guideline for bone metabolism and disease in ckd: Association with mortality in dialysis patients. Am J Kidney Dis 2005;46:925-932 (Pubitemid 41505468)
16. Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A: Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 2004;15:770-779 (Pubitemid 38294808)
17. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218 (Pubitemid 39031360)
18. Danese MD, Belozeroff V, Smirnakis K, Rothman KJ: Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol 2008;2:2
19. Ansell DF, T.G. (eds): Renal registry 7th annual report. In chapter 6: Adequacy of haemodialysis and serum bicarbonate, 2004, pp 59-86